Risks of Combining Sedatives and Opioids

Pharmacological Interaction Risks

The FDA has issued a black box warning about the serious risks of combining opioids with sedative medications, including slowed or difficult breathing and death 1
When benzodiazepines and opioids were used together in studies, hypoxemia occurred in 92% of subjects, and apnea occurred in 50%, demonstrating the dangerous synergistic respiratory effects 2
The combination significantly increases the risk of oversedation, which often precedes respiratory depression 1

Studies examining patterns of opioids and sedative-hypnotics prescribing have identified a 3- to 10-fold higher risk of death when these agents are co-prescribed compared to opioids alone 3
Mortality rates associated with benzodiazepines and similar sedative medications have shown trends similar to those seen with opioid overdose deaths 3

If both medications must be used, prescribe the lowest effective doses of both medications 3
Consider having naloxone available for caregivers to administer in case of respiratory depression 1
Monitor closely for progressive sedation, which often precedes respiratory depression 1

For insomnia in patients requiring opioid therapy, consider non-sedating alternatives for sleep management 4

Patients with limited cardiopulmonary reserve are more susceptible to respiratory depression, and hypercarbia occurs before hypoxia 1

Hydrocodone is not classified among serotonergic opioids (e.g., tramadol, tapentadol, methadone, fentanyl, meperidine, levorphanol); nevertheless, clinicians should apply the usual opioid safety precautions—including assessment of respiratory risk, dose titration, and monitoring for sedation—when prescribing hydrocodone, especially in combination with other CNS depressants such as trazodone. [5][6]7